Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate being evaluated in the OPUS Phase 3 adult clinical program and in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-31 and VAX-24 are designed to improve upon standard-of-care PCVs by covering the serotypes in circulation that cause a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains. VAX-XL, in earlier-stage development, also leverages the Company’s carrier-sparing, site-specific conjugation technology with the aim of further expanding coverage to deliver the broadest-spectrum candidate in the Company’s PCV franchise.
- Founded
- 2013
- Company size
- 201-500
- Headquarters
- San Carlos, California, US
- Funding
- Post Ipo Equity
Hiring activity
- Open roles
- 15
- Posted in the last 30 days
- 16
Updated 6h ago
What Vaxcyte says about its culture
We are on a global mission to engineer high-fidelity vaccines that protect humankind from the consequences of bacterial diseases.
We define success in human terms
“We define success in human terms, protecting every child born and every adult at risk from bacterial infectious diseases across the globe.”Source
We push beyond what seems possible
“We push beyond what seems possible, unbounded by the constraints of convention, the limits of technology or the magnitude of our challenge.”Source
We re-engineer complexity
“We re-engineer complexity, with the chemistry to create precisely targeted vaccines intended to deliver enhanced immunological benefits.”Source
We embrace the unknown
“We embrace the unknown, deftly navigating our development journey with the care, passion, courage and commitment to excellence to defy the odds.”Source
They say people do well here who…
- Willing to take initiative and 'raise their hand' for opportunities
- Being both fearless and kind when tackling tough challenges
- Collaborative and team-oriented, inclusive, creative
- Leading with heart and caring about colleagues and quality of work
Quoted from Vaxcyte's own website. TeaKo does not verify these claims.
Latest openings
15 open roles at Vaxcyte. Members see each one.
